Kuczkowski Jerzy, Mikaszewski Bogusław, Pawełczykl Tadeusz
Katedra i Klinika Chorób Uszu, Nosa, Gardła i Krtani AM w Gdańsku.
Otolaryngol Pol. 2006;60(5):723-8.
Telomerase is an enzyme responsible for maintaining the constant length of chromosomal telomers, which are necessary for normal function of eucaryotic cells. Presence of active telomerase in neoplastic cells prevents shortening of telomers what makes this cells immortal. Telomerase plays an important role in carcinogenesis. Aim of this study was to investigate the activity of telomerase in head and neck tumors and assess its diagnostic and prognostic value.
Material consisted of 30 head and neck tumors treated surgically and 9 samples from healthy skin and mucous membranes. Telomerase activity was investigated using TeloTAGGG Telomerase PCR ELISA method.
Telomerase activity was found in 24 (80%) malignant tumors. Relative activity of telomerase in neoplasms was from 16.9 to 766,2 RTA. Telomerase expression was much lower in samples of healthy skin and mucous membrane (RTA <5). Statistically significant difference was proven for T1 and T2 tumors, comparing to T4 tumors (p < 0.05). No statistically significant difference in telomerase activity for G1 and G2 differentiation tumors comparing to G3 and for tumors without lymph nodes metastases comparing to tumors with metastases.
Malignant head and neck tumors show high activity of telomerase comparing to healthy tissue. Detection of telomerase activity in head and neck malignant neoplasms can be a useful marker for cancer assessment. The quantification of telomerase activity has clinical diagnostic value for head and neck malignant neoplasms. To make a convenience of telomerase as a marker for diagnostic and prognosis in patients with malignant head and neck tumor needs further investigations.
端粒酶是一种负责维持染色体端粒恒定长度的酶,而端粒对于真核细胞的正常功能是必需的。肿瘤细胞中活性端粒酶的存在可防止端粒缩短,从而使这些细胞具有永生性。端粒酶在肿瘤发生过程中起重要作用。本研究的目的是调查头颈部肿瘤中端粒酶的活性,并评估其诊断和预后价值。
材料包括30例接受手术治疗的头颈部肿瘤以及9份来自健康皮肤和黏膜的样本。使用TeloTAGGG端粒酶PCR ELISA方法检测端粒酶活性。
在24例(80%)恶性肿瘤中发现了端粒酶活性。肿瘤中端粒酶的相对活性为16.9至766.2 RTA。健康皮肤和黏膜样本中的端粒酶表达要低得多(RTA <5)。与T4肿瘤相比,T1和T2肿瘤的端粒酶活性差异具有统计学意义(p < 0.05)。G1和G2分化肿瘤与G3肿瘤相比,以及无淋巴结转移的肿瘤与有转移的肿瘤相比,端粒酶活性无统计学显著差异。
与健康组织相比,恶性头颈部肿瘤显示出较高的端粒酶活性。检测头颈部恶性肿瘤中的端粒酶活性可作为癌症评估的有用标志物。端粒酶活性的定量对头颈部恶性肿瘤具有临床诊断价值。要使端粒酶方便地作为头颈部恶性肿瘤患者诊断和预后的标志物,还需要进一步研究。